CONEXEU SCIENCES INC
CNXU · NASDAQ
Updated at 2026-10-13 15:06:24
- Today's High
- $3.98
- Today’s Low
- $3.53
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $4.10
- Previous Close
- $3.77
- Volume
- 363.12K
- Market Cap
- $106.33M
- P/E Ratio
- --
- EPS
- $-0.66
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 50 WEST LIBERTY STREET, RENO, NV, UNITED STATES, 89501
- Country
- US
- Listing Date
- 2026-05-21
- Fiscal Year End
- October
- Shares Outstanding
- 26.76M
- CIK
- --
- Website
- www.conexeu.com
Conexeu Sciences Inc. (CNXU) is an innovative biotechnology company committed to enhancing healthcare through the development of advanced diagnostics and therapeutics. Leveraging cutting-edge technology, Conexeu aims to deliver products that not only improve patient outcomes but also lower healthcare costs. With a robust emphasis on research and development, the company stands at the forefront of significant medical advancements, positioning itself as an attractive investment opportunity in the burgeoning biotech sector. Through strategic collaborations and a diverse product pipeline, Conexeu is focused on addressing critical unmet medical needs, appealing to institutional investors looking to engage with breakthrough health solutions.
Financial Metrics
Revenue
2026-07-31
$0
2026-04-30
$0
2026-01-31
$0
2025-10-31
$0
Operating Expenses
2026-07-31
$7.68M
2026-04-30
$2.37M
2026-01-31
$1.72M
2025-10-31
$1.87M
Net Income
2026-07-31
-$7.72M
2026-04-30
-$2.3M
2026-01-31
-$1.71M
2025-10-31
-$1.87M
Net Profit Margin
2026-07-31
--
2026-04-30
--
2026-01-31
--
2025-10-31
--
Earnings Per Share
2026-07-31
$-0.29
2026-04-30
$-0.08
2026-01-31
--
2025-10-31
--
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-07-31
-$7.71M
2026-04-30
-$2.29M
2026-01-31
-$1.71M
2025-10-31
-$1.87M
Effective Tax Rate
2026-07-31
--
2026-04-30
--
2026-01-31
--
2025-10-31
--
| Item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $7.68M | $2.37M | $1.72M | $1.87M |
| Net Income | -$7.72M | -$2.3M | -$1.71M | -$1.87M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.29 | $-0.08 | -- | -- |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$7.71M | -$2.29M | -$1.71M | -$1.87M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.